Barclays Raises Tenet Healthcare (NYSE:THC) Price Target to $147.00

Tenet Healthcare (NYSE:THC – Get Free Report) had its price objective raised by research analysts at Barclays from $113.00 to $147.00 in a research note issued on Thursday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price objective points to a potential upside of 22.21% from the company’s previous close. […]

Related Keywords

United States ,Richardw Fisher , ,Rise Advisors ,Fidelis Capital Partners ,Sunbelt Securities Inc ,Deutsche Bank Aktiengesellschaft ,Tenet Healthcare Corporation ,Tenet Healthcare ,Tenet Healthcare Company Profile ,Wolfe Research ,Barclays ,Fintrust Capital Advisors ,Cantor Fitzgerald ,Get Free Report ,Director Richard ,Trust Capital Advisors ,Healthcare Corporation ,Hospital Operations ,Tenet Healthcare Daily ,